AnaptysBio Inc buy Guggenheim
Start price
21.10.24
/
50%
€32.80
Target price
21.10.25
€83.18
Performance (%)
-12.20%
End price
22.10.25
€28.80
Summary
This prediction ended on 22.10.25 with a price of €28.80. The prediction for AnaptysBio Inc disappointed with a performance of -12.20%. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 2.758% | 2.758% | 175.227% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $75.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten